Expression of excitatory amino acid transporter-1 in brain macrophages and microglia of HIV-infected patients. A neuroprotective role for activated microglia?

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 5, 2003, Pages 475-485

  Valérie Vallat Decouvelaere, Anne ^a   Chrétien, Fabrice ^b   Gras, Gabriel ^d   Le Pavec, Gwenaelle ^d   Dormont, Dominique ^d   Gray, Françoise ^c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c RAYMOND POINCARÉ HOSPITAL   (France)

^d INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

Central nervous system; Excitatory amino acid transporter; Glutamate; HIV dementia; Human immunodeficiency virus; Macrophage; Microglia

Indexed keywords

ANTIRETROVIRUS AGENT; CD68 ANTIGEN; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMIC ACID; GLUTATHIONE; HLA DR ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; AMINO ACID TRANSPORT; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN TISSUE; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENCEPHALITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MICROGLIA; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHITE MATTER;

EID: 18344403959     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.5.475     Document Type: Article

References (56)

1. Chrétien F, Vallat-Decouvelaere AV, Le Pavec G, et al. Expression of glutamate transporter EAAT1 in the brain of HIV-infected patients. (Abstract) J Neuro Virol 2002;8:27
2. Gray F, Adle-Biassette H, Brion F, et al. Neuronal apoptosis in human immunodeficiency virus infection. J Neurovirol 2000;6: S38-S43
3. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001;410:988-94
4. Everall I, Luthert P, Lantos P. A review of neuronal damage in human immunodeficiency virus infection: Its assessment, possible mechanism and relationship to dementia. J Neuropathol Exp Neurol 1993;52:561-66
5. Gray F, Adle-Biassette H, Chretien F, Lorin de la Grandmaison G, Force G, Keohane C. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol 2001;20:146-55
6. Adle-Biassette H, Chretien F, Wingertsmann L, et al. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 1999;25:123-33
7. Adle-Biassette H, Levy Y, Colombel M, et al. Neuronal apoptosis in HIV infection in adults. Neuropathol Appl Neurobiol 1995;21: 218-27
8. Gelbard HA, James HJ, Sharer LR, et al. Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol Appl Neurobiol 1995;21: 208-17
9. Petito CK, Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 1995;146:1121-30
10. Shi B, De Girolami U, He J, et al. Apoptosis induced by HIV-1 infection of the central nervous system. J Clin Invest 1996;98: 1979-90
11. Vallat AV, De Girolami U, He J, et al. Localization of HIV-1 coreceptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol 1998;152:167-78
12. Adamson DC, Wildemann B, Sasaki M, et al. Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996;274:1917-21
13. Boven LA, Gomes L, Hery C, et al, Increased peroxynitrite activity in AIDS dementia complex: Implications for the neuropathogenesis of HIV-1 infection. J Immunol 1999;162:4319-27
14. Shi B, Raina J, Lorenzo A, Busciglio J, Gabuzda D. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: Potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J Neurovirol 1998;4:281-90
15. Barks JD, Liu XH, Sun R, Silverstein FS. gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats. Neuroscience 1997;76:397-409
16. Haughey NJ, Nath A, Mattson MP, Slevin JT, Geiger JD. HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J Neurochem 2001;78:457-67
17. + exchangers, excitatory amino acid receptors and voltage-operated Ca2+ channels in human immunodeficiency virus type 1 gp120-mediated increases in intracellular Ca2+ in human neurons and astrocytes. Neuroscience 1999;91:1369-78
18. Jiang ZG, Piggee C, Heyes MP, et al. Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J Neuroimmunol 2001;117:97-107
19. Lipton SA. Calcium channel antagonists and human immunodeficiency virus coat protein-mediated neuronal injury. Ann Neurol 1991;30:110-14
20. Lipton SA. HIV-related neurotoxicity. Brain Pathol 1991;1: 193-99
21. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 1991;7:111-18
22. Rothstein JD, Martin L, Levey AI, et al. Localization of neuronal and glial glutamate transporters. Neuron 1994;13:713-25
23. Rothstein JD, Dykes-Hoberg M, Pardo CA, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in I excitotoxicity and clearance of glutamate. Neuron 1996;16:675-86
24. Danbolt NC. Glutamate uptake. Prog Neurobiol 2001;65:1-105
25. Rimaniol AC, Mialocq P, Clayette P, Dormont D, Gras G. Role of glutamate transporters in the regulation of glutathione levels in human macrophages. Am J Physiol Cell Physiol 2001;281:C1964-70
26. Reichelt W, Stabel-Burow J, Pannicke T, Weichert H, Heinemann U. The glutathione level of retinal Muller glial cells is dependent on the high-affinity sodium-dependent uptake of glutamate. Neuroscience 1997;77:1213-24
27. Dreyer EB, Lipton SA. The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur J Neurosci 1995;7:2502-7
28. Fine SM, Angel RA, Perry SW, et al. Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J Biol Chem 1996;271: 15303-6
29. Kort JJ. Impairment of excitatory amino acid transport in astroglial cells infected with the human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1998;14:1329-39
30. +) conductance, and glutamate flux. Am J Physiol Cell Physiol 2000;279:C700-708
31. Vesce S, Bezzi P, Rossi D, Meldolesi J, Volterra A. HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid. FEBS Lett 1997;411:107-9
32. Kondo K, Hashimoto H, Kitanaka J, et al. Expression of glutamate transporters in cultured glial cells. Neurosci Lett 1995;188:140-42
33. Nakajima K, Tohyama Y, Kohsaka S, Kurihara T. Ability of rat microglia to uptake extracellular glutamate. Neurosci Lett 2001; 307:171-74
34. Noda M, Nakanishi H, Akaike N. Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience 1999;92:1465-74
35. +-dependent highaffinity glutamate transport in macrophages. J Immunol 2000; 164:5430-38
36. Swanson RA, Liu J, Miller JW, et al, Neuronal regulation of glutamate transporter subtype expression in astrocytes. J Neurosci 1997;17:932-40
37. Lopez-Redondo F, Nakajima K, Honda S, Kohsaka S. Glutamate transporter GLT-1 is highly expressed in activated microglia following facial nerve axotomy. Brain Res Mol Brain Res 2000;76: 429-35
38. van Landeghern FK, Stover JF, Bechmann I, et al. Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat. Glia 2001;35:167-79
39. Chrétien F, Vallat-Decouvelaere AV, Bossuet C, et al. Expression of excitatory amino acid transporter-2 (EAAT-2) and glutamine synthetase (GS) in brain macrophages and microglia of SIVmac251-infected macaques. Neuropathol Appl Neurobiol 2002;28:410-17
40. Gray F, Scaravilli F, Everall I, et al. Neuropathology of early HIV-1 infection. Brain Pathol 1996;6:1-15
41. Créminon C, Déry O, Frobert Y, Couraud Y, Pradelles P, Grassi J. Two-site immunometric assay for substance P with increased sensitivity and specificity. Anal Chem 1995;67:1617-22
42. Créminon C, Frobert Y, Habib A, et al. Enzyme immunometric assay for endothelin using tandem monoclonal antibodies. J Immunol Methods 1993;162:179-92
43. Chaudhry FA, Lehre KP, van Lookeren Campagne M, Ottersen OP, Danbolt NC, Storm-Mathisen J. Glutamate transporters in glial plasma membranes: Highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 1995;15: 711-20
44. -]coupled L-glutamate transporter purified from rat brain is located in glial cell processes. Neuroscience 1992;51:295-310
45. +]coupled an L-glutamate transporter purified from rat brain confirms glial cell localization. FEBS Lett 1993;317:79-84
46. Chao CC, Hu S, Tsang M, et al. Effects of transforming growth factor-beta on murine astrocyte glutamine synthetase activity. Implications in neuronal injury. J Clin Invest 1992;90:1786-89
47. Sung JH, Shin SA, Park HK, Montelaro RC, Chong YH. Protective effect of glutathione in HIV-1 lytic peptide 1-induced cell death in human neuronal cells. J Neurovirol 2001;7:454-65
48. Glass JD, Wesselingh SL, Selnes OA, McArthur JC. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 1993;43:2230-37
49. An SF, Giometto B, Scaravilli T, Tavolato B, Gray F, Scaravilli F. Programmed cell death in brains of HIV-1-positive AIDS and preAIDS patients. Acta Neuropathol (Berl) 1996;91:169-73
50. Sinclair E, Gray F, Ciardi A, Scaravilli F. Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. J Neuropathol Exp Neurol 1994;53:43-50
51. Everall I, Gray F, Barnes H, Durigon M, Luthert P, Lantos P. Neuronal loss in symptom-free HIV infection. Lancet 1992;340: 1413
52. An SF, Gray F. Scaravilli F. Programmed cell death in brains of HIV-1-positive pre-AIDS patients. Lancet 1995;346:911-12
53. Sacktor NC, Lyles RH, Skolasky RL, et al. Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology 1999;52:1640-47
54. Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC. Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J Neurovirol 2000;6:84-88
55. Ferrarese C, Aliprandi A, Tremolizzo L, et al. Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 2001; 57:671-75
56. Neuen-Jacob E, Kuckert S, Kümmel T. Dysregulation of the glutaminergic system plays an important role in the pathogenesis of HIV dementia. (Abstract) J Neuro Virol 2002;8:27